New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
WILMINGTON, Del.--(BUSINESS WIRE)--May 19, 2024--
Stay updated with breaking news from Inflammatory Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WILMINGTON, Del.--(BUSINESS WIRE)--May 19, 2024--
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International...
New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD ...
Recent research has revealed that neotame, part of the newer generation of artificial sweeteners, can harm the human intestine and induce illness.
Gilead Sciences has celebrated the opening of its new research site at the Business Park in Oxford with a ribbon-cutting event.